Skip to Main Content

Skip Nav Destination

635. Myeloproliferative Syndromes: Basic Science: Translational Studies| December 2, 2016

Enhanced MAPK Signaling Constitute Non-Oncogene Addiction in CSF3R Induced Leukemia

Sara Rohrabaugh, PhD,

Sara Rohrabaugh, PhD *

1Pathology, CBDI, CCHMC, Cincinnati, OH

Search for other works by this author on:

PubMed

Google Scholar

Meenu Kesarwani, PhD,

Meenu Kesarwani, PhD *

2Cncinnati Childrens Hospital, Cicninnati,

Search for other works by this author on:

PubMed

Google Scholar

Zachary Kincaid, BS,

Zachary Kincaid, BS *

3Pathology, Cincinnati Childrens Hospital, Cicninnati, OH

Search for other works by this author on:

PubMed

Google Scholar

Erika Huber,

Erika Huber *

4Cincinnati Children's Hospital Medical Center, Cincinnati,

Search for other works by this author on:

PubMed

Google Scholar

H. Leighton Grimes, PhD,

H. Leighton Grimes, PhD

5Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Search for other works by this author on:

PubMed

Google Scholar

Mohammad Azam, PhD

Mohammad Azam, PhD

6Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Search for other works by this author on:

PubMed

Google Scholar

Blood (2016) 128 (22): 632.

https://doi.org/10.1182/blood.V128.22.632.632

Abstract

View large Download slide

Disclosures

No relevant conflicts of interest to declare.

Author notes

*

Asterisk with author names denotes non-ASH members.

This icon denotes a clinically relevant abstract

© 2016 by The American Society of Hematology

2016

Sign in via your Institution

Supplemental data